Literature DB >> 9729536

Role of arachidonic acid and its metabolites in the priming of NADPH oxidase in human polymorphonuclear leukocytes by peritoneal dialysis effluent.

I Daniels1, M A Lindsay, C I Keany, R P Burden, J Fletcher, A P Haynes.   

Abstract

Peritoneal dialysis effluent (PDE) contains a low-molecular-weight solute that will activate and prime the NADPH oxidase of human neutrophils via a phospholipase A2 (PLA2)-dependent mechanism. Since the products of PLA2 are known to activate and prime the oxidase we have investigated their role in the dialysis effluent-mediated activation and priming of human neutrophils. NADPH oxidase activity of PDE-primed and -unprimed neutrophils was measured by lucigenin-enhanced chemiluminescence in the presence of known inhibitors of the arachidonic acid cascade. Incubation of neutrophils with the nonselective PLA2 inhibitor quinacrine (0 to 100 microM) reduced oxidase activity in both primed and unprimed cells. Furthermore, primed cells were more sensitive to the action of quinacrine than were unprimed cells. We were unable to determine the relative roles of secretory PLA2 (sPLA2) and cytosolic PLA2 (cPLA2) since the selective sPLA2 inhibitor scalaradial (0 to 100 microM) inhibited oxidase activity in both groups of cells by similar degrees, while the specific cPLA2 inhibitor AACO-CF3 (0 to 50 microM) failed to affect activity in either group. Inhibition of platelet-activating factor (PAF), cycloxygenase, and 5-lipoxygenase-activating protein by hexanolamino-PAF (0 to 25 microM), flurbiprofen (0 to 25 microM), and MK886 (0 to 5 microM), respectively, had no effect upon oxidase activity. However, the direct inhibition of 5-lipoxygenase by caffeic acid or lipoxin A4 resulted in a similar concentration-dependent attenuation of oxidase activity in both primed and unprimed cells. Leukotriene B4 (LTB4) release from primed neutrophils was comparable to that from unprimed cells with the exception of phorbol myristate acetate-stimulated cells, which released fivefold more LTB4 than control. Taken together, these results suggest that it is arachidonic acid per se, and not its metabolites, that is important in priming of the neutrophil NADPH oxidase by dialysis effluent.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9729536      PMCID: PMC95640          DOI: 10.1128/CDLI.5.5.683-689.1998

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  52 in total

1.  Activation of NADPH oxidase in human neutrophils. Synergism between fMLP and the neutrophil products PAF and LTB4.

Authors:  B Dewald; M Baggiolini
Journal:  Biochem Biophys Res Commun       Date:  1985-04-16       Impact factor: 3.575

2.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

3.  Serum-coated zymosan stimulates the synthesis of leukotriene B4 in human polymorphonuclear leukocytes. Inhibition by cyclic AMP.

Authors:  H E Claesson; U Lundberg; C Malmsten
Journal:  Biochem Biophys Res Commun       Date:  1981-04-30       Impact factor: 3.575

4.  Leukotriene B4 is a complete secretagogue in human neutrophils: a kinetic analysis.

Authors:  C N Serhan; A Radin; J E Smolen; H Korchak; B Samuelsson; G Weissmann
Journal:  Biochem Biophys Res Commun       Date:  1982-08       Impact factor: 3.575

5.  Phagocytosis-induced release of arachidonic acid from human neutrophils.

Authors:  M Waite; L R DeChatelet; L King; P S Shirley
Journal:  Biochem Biophys Res Commun       Date:  1979-10-12       Impact factor: 3.575

6.  Characterization of effect of N-formyl-methionyl-leucyl-phenylalanine on leukotriene synthesis in human polymorphonuclear leukocytes.

Authors:  H Salari; P Braquet; P Naccache; P Borgeat
Journal:  Inflammation       Date:  1985-06       Impact factor: 4.092

7.  Metabolic, membrane, and functional responses of human polymorphonuclear leukocytes to platelet-activating factor.

Authors:  L M Ingraham; T D Coates; J M Allen; C P Higgins; R L Baehner; L A Boxer
Journal:  Blood       Date:  1982-06       Impact factor: 22.113

8.  Release and metabolism of arachidonic acid in human neutrophils.

Authors:  C E Walsh; B M Waite; M J Thomas; L R DeChatelet
Journal:  J Biol Chem       Date:  1981-07-25       Impact factor: 5.157

9.  Caffeic acid is a selective inhibitor for leukotriene biosynthesis.

Authors:  Y Koshihara; T Neichi; S Murota; A Lao; Y Fujimoto; T Tatsuno
Journal:  Biochim Biophys Acta       Date:  1984-01-17

10.  Release of leukotriene B4 from human neutrophils and its relationship to degranulation induced by N-formyl-methionyl-leucyl-phenylalanine, serum-treated zymosan and the ionophore A23187.

Authors:  R M Palmer; J A Salmon
Journal:  Immunology       Date:  1983-09       Impact factor: 7.397

View more
  8 in total

1.  Role of p38 in the priming of human neutrophils by peritoneal dialysis effluent.

Authors:  I Daniels; J Fletcher; A P Haynes
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

2.  Sustained activation of proton channels and NADPH oxidase in human eosinophils and murine granulocytes requires PKC but not cPLA2 alpha activity.

Authors:  Deri Morgan; Vladimir V Cherny; Alison Finnegan; James Bollinger; Michael H Gelb; Thomas E DeCoursey
Journal:  J Physiol       Date:  2006-12-21       Impact factor: 5.182

3.  Ceramide kinase regulates TNFα-stimulated NADPH oxidase activity and eicosanoid biosynthesis in neuroblastoma cells.

Authors:  Brian M Barth; Sally J Gustafson; Jody L Hankins; James M Kaiser; Jeremy K Haakenson; Mark Kester; Thomas B Kuhn
Journal:  Cell Signal       Date:  2011-12-30       Impact factor: 4.315

Review 4.  Targeting NADPH oxidase and phospholipases A2 in Alzheimer's disease.

Authors:  Agnes Simonyi; Yan He; Wenwen Sheng; Albert Y Sun; W Gibson Wood; Gary A Weisman; Grace Y Sun
Journal:  Mol Neurobiol       Date:  2010-03-02       Impact factor: 5.590

5.  Cytosolic phospholipase A2-alpha is necessary for platelet-activating factor biosynthesis, efficient neutrophil-mediated bacterial killing, and the innate immune response to pulmonary infection: cPLA2-alpha does not regulate neutrophil NADPH oxidase activity.

Authors:  Barry B Rubin; Gregory P Downey; Adeline Koh; Norbert Degousee; Farideh Ghomashchi; Laxman Nallan; Eva Stefanski; Denis W Harkin; Chunxiang Sun; Brian P Smart; Thomas F Lindsay; Vera Cherepanov; Eric Vachon; David Kelvin; Martin Sadilek; Glenn E Brown; Michael B Yaffe; Jonathan Plumb; Sergio Grinstein; Michael Glogauer; Michael H Gelb
Journal:  J Biol Chem       Date:  2004-10-08       Impact factor: 5.157

6.  NADPH oxidase-2: linking glucose, acidosis, and excitotoxicity in stroke.

Authors:  Angela M Brennan-Minnella; Seok Joon Won; Raymond A Swanson
Journal:  Antioxid Redox Signal       Date:  2015-01-10       Impact factor: 8.401

7.  Protective effect of quinacrine against glycerol-induced acute kidney injury in rats.

Authors:  Abdulrahman K Al Asmari; Khalid Tariq Al Sadoon; Ali Ahmed Obaid; Deivakadatcham Yesunayagam; Mohammad Tariq
Journal:  BMC Nephrol       Date:  2017-01-28       Impact factor: 2.388

8.  The subcellular localization of the receptor for platelet-activating factor in neutrophils affects signaling and activation characteristics.

Authors:  Emil Andréasson; Karin Önnheim; Huamei Forsman
Journal:  Clin Dev Immunol       Date:  2013-08-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.